You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

completed at least 2 cycles of salvage chemotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced or Metastatic Colorectal Cancer (mCRC) Trial (CA102N)

Available
  • Advanced or Metastatic Colorectal Cancer (mCRC)
  • (no location specified)
Mar 2, 2022

Chemo-Induced Thrombocytopenia Trial (Hetrombopag, Matching )

Not yet recruiting
  • Chemotherapy-Induced Thrombocytopenia
  • (no location specified)
Feb 21, 2022

Nasopharyngeal Carcinoma Trial in Guangzhou (SHR-1210)

Completed
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
    Cancer Center of Sun-Yat Sen University (CCSYSU)
Apr 1, 2022

Esophagus Squamous Cell Carcinoma Trial in Beijing (Palbociclib, Afatinib)

Recruiting
  • Esophagus Squamous Cell Carcinoma
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
May 17, 2023

Metastatic Breast Cancer (MBC) Trial in Nanjing, Shanghai (Paclitaxel Polymeric Micelles for Injection, Eribulin Mesilate

Recruiting
  • Metastatic Breast Cancer (MBC)
  • Paclitaxel Polymeric Micelles for Injection
  • +5 more
  • Nanjing, Jiangsu, China
  • +2 more
Nov 21, 2023

Metastatic Breast Cancer Trial (SKB264, Eribulin, Capecitabine)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Oct 7, 2023

CNS Lymphoma, CNS Brain Cancer, Non-Hodgkin's Lymphoma Trial in Basking Ridge, Commack, New York (Rituximab, Methotrexate,

Active, not recruiting
  • CNS Lymphoma
  • +2 more
  • Rituximab, Methotrexate, Vincristine, Procarbazine, PBPCs collection, Busulfan, Thiotepa, and Cyclophosphamide
  • Basking Ridge, New Jersey
  • +2 more
Jan 27, 2023

Ovarian Cancer Trial in Hungary, United Kingdom, United States (EP0057, Olaparib tablets)

Recruiting
  • Ovarian Cancer
  • Lady Lake, Florida
  • +15 more
Mar 29, 2022

Follicular Lymphoma Trial in Italy (Immunochemo regimen: Rituximab-bendamustine (Arm A), Immunochemo regimen:

Recruiting
  • Follicular Lymphoma
  • Immunochemotherapy regimen: Rituximab-bendamustine (Arm A)
  • +9 more
  • Barletta, Barletta Andria Trani, Italy
  • +68 more
Oct 13, 2022

Melanoma Trial in Beijing, Nanjing, Hangzhou (OH2, Salvage chemo or best supportive care)

Recruiting
  • Melanoma
  • OH2
  • Salvage chemotherapy or best supportive care
  • Beijing, Beijing, China
  • +2 more
May 11, 2023

Lymphoma Trial (pegfilgrastim, rituximab, cyclophosphamide)

Completed
  • Lymphoma
  • pegfilgrastim
  • +5 more
  • (no location specified)
Jul 2, 2021

Advanced Ovarian Cancer Trial in Fujian (SC10914)

Unknown status
  • Advanced Ovarian Cancer
  • Fujian, China
    Fujian Cancer Hospital
May 11, 2021

Leukemia, Acute Myeloid (AML) Trial in Worldwide (gilteritinib, LoDAC (Low Dose Cytarabine), Azacitidine)

Active, not recruiting
Has Results
  • Leukemia, Acute Myeloid (AML)
  • Birmingham, Alabama
  • +125 more
Aug 9, 2022

Marginal Zone Lymphoma Trial (Mosunetuzumab + Lenalidomide, - Rituximab + Lenalidomide (28-days cycles, - Rituximab +

Not yet recruiting
  • Marginal Zone Lymphoma
  • Mosunetuzumab + Lenalidomide
  • +3 more
  • (no location specified)
Aug 16, 2023

Lymphoma Trial in Worldwide (bleomycin sulfate, filgrastim, pegfilgrastim)

Completed
  • Lymphoma
  • bleomycin sulfate
  • +12 more
  • Garran, Australian Capital Territory, Australia
  • +139 more
Dec 19, 2022

Prostate Cancer Trial in United States (Vinflunine)

Completed
Has Results
  • Prostate Cancer
  • Fort Myers, Florida
  • +11 more
Dec 14, 2021

Metastatic Breast Cancer Trial in China, Korea, Republic of, Taiwan (sacituzumab govitecan (IMMU-132), Eribulin Mesylate

Recruiting
  • Metastatic Breast Cancer
  • sacituzumab govitecan (IMMU-132)
  • +4 more
  • Beijing, China
  • +43 more
Apr 19, 2022

AML, MDS Trial in Tuebingen (Decitabine, Venetoclax)

Recruiting
  • AML
  • MDS
  • Tuebingen, Baden-Wuerttemberg, Germany
    University Hospital
Nov 30, 2023

Sintilimab and Anlotinib in Combination With Chemo Trial in Xi'an (Sintilimab and anlotinib in combination with chemo)

Completed
  • Sintilimab and Anlotinib in Combination With Chemotherapy
  • Sintilimab and anlotinib in combination with chemotherapy
  • Xi'an, Shanxi, China
  • +1 more
Aug 27, 2023

Glioblastoma Trial run by the NCI (drug, biological, other)

Completed
  • Glioblastoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 23, 2022

DLBCL, Not Otherwise Specified Trial in Chongqing (selinexor)

Recruiting
  • Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Mar 27, 2023

Relapsed Diffuse Large B-cell Lymphoma, Refractory DLBCL Trial in Worldwide (Polatuzumab Vedotin, Mabthera, Ifosfamide)

Recruiting
  • Relapsed Diffuse Large B-cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Polatuzumab Vedotin
  • +4 more
  • Graz, Austria
  • +62 more
Aug 2, 2022

Breast Cancer Trial in Seoul (Extracorporeal shock waves)

Recruiting
  • Breast Cancer
  • Extracorporeal shock waves
  • Seoul, Yangcheon Gu, Korea, Republic of
    Kiwhan Kim
Oct 25, 2022

HER2-positive Breast Cancer, ER-Negative Breast Cancer, PR-Negative Breast Cancer Trial in Belgium, France (Pertuzumab and

Recruiting
  • HER2-positive Breast Cancer
  • +3 more
  • Pertuzumab and tratuzumab fixed dose combination
  • Trastuzumab emtansine
  • Auchenflower, Australia
  • +84 more
Jan 16, 2023

Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity Trial in Canada, United States (OLAPARIB)

Completed
Has Results
  • Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity
  • Anchorage, Alaska
  • +46 more
Mar 22, 2022